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DOI 10.1016/j.cell.2011.12.035SUMMARY (Li et al., 1992; Okano et al., 1999). Cytosine methylation canDifferential methylation of the two parental genomes
in placental mammals is essential for genomic
imprinting and embryogenesis. To systematically
study this epigenetic process, we have generated
a base-resolution, allele-specific DNA methylation
(ASM) map in the mouse genome. We find parent-
of-origin dependent (imprinted) ASM at 1,952 CG
dinucleotides. These imprinted CGs form 55 discrete
clusters including virtually all known germline differ-
entially methylated regions (DMRs) and 23 previously
unknown DMRs, with some occurring at microRNA
genes. We also identify sequence-dependent ASM
at 131,765 CGs. Interestingly, methylation at these
sites exhibits a strong dependence on the immediate
adjacent bases, allowing us to define a conserved
sequence preference for the mammalian DNA meth-
ylation machinery. Finally, we report a surprising
presence of non-CG methylation in the adult mouse
brain, with some showing evidence of imprinting.
Our results provide a resource for understanding
the mechanisms of imprinting and allele-specific
gene expression in mammalian cells.
INTRODUCTION
In mammals, DNA methylation plays a critical role in genomic
imprinting, X chromosome inactivation, cellular differentiation,
and development (Bird, 2002). Occurring primarily on cytosine
within a CG dinucleotide, DNAmethylation is considered amajor
epigenetic mark responsible for silencing of cell-fate regulators
during development (Reik et al., 2001). DNA methylation is es-
tablished by the de novo DNA methyltransferases DNMT3A
and DNMT3B and maintained by the DNA methyltransferase
DNMT1 (Chen and Li, 2004). Mutations that compromise the
DNA methylation machinery result in early embryonic lethality816 Cell 148, 816–831, February 17, 2012 ª2012 Elsevier Inc.also occur in non-CG contexts including CHH and CHG (where
H = A, C, or T) as shown in embryonic stem cells (Lister et al.,
2009; Ramsahoye et al., 2000; Ziller et al., 2011), oocytes, and
preimplantation embryos (Haines et al., 2001; Imamura et al.,
2005; Tomizawa et al., 2011). Non-CG methylation is largely
depleted from adult somatic cells previously examined (Lister
et al., 2011; Ramsahoye et al., 2000; Ziller et al., 2011) with
a few exceptions (Dyachenko et al., 2010).
A subset of mammalian genes are only transcribed from one
parental allele leading to parent-of-origin specific expression or
genomic imprinting (Bartolomei and Ferguson-Smith, 2011;
Reik and Walter, 2001). Such genomic imprinting is crucial for
embryonic development as mouse embryos containing only
maternal or paternal genomes failed to develop normally (Surani
et al., 1990). In humans, loss of imprinting contributes to the
development of a number of diseases including Prader-Willi
Syndrome, Angelman Syndrome, Beckwith-Wiedemann
Syndrome, and cancer (Lalande, 1996). Many imprinted genes
are known to be expressed in the brain and are involved in neuro-
development (Wilkinson et al., 2007). Imprinted expression is
often directly controlled by the differentially methylated regions
(DMRs) harboring parent-of-origin dependent, allele-specific
DNA methylation (ASM). Some DMRs acquire their allelic meth-
ylation status during gametogenesis (germline DMRs, or
gDMRs), and the status is then maintained throughout develop-
ment (Reik and Walter, 2001). Other DMRs become allelicly
methylated only later in development (somatic DMRs, or
sDMRs), often in a tissue-specific manner. In mice, several
large-scale efforts have been carried out to identify imprinted
DMRs (Hayashizaki et al., 1994; Hiura et al., 2010; Kelsey
et al., 1999; Peters et al., 1999; Plass et al., 1996; Singh et al.,
2011; Smith et al., 2003). Yet, currently the number of known im-
printed DMRs is still very limited. Less than 30 well-validated
gDMRs have been reported in mice or humans (Chotalia et al.,
2009; Hiura et al., 2010; Schulz et al., 2008).
Allelic DNA methylation can also arise in a way that is
dependent on the sequence context (Tycko, 2010). Such ASM
has been found in humans and mice, with some linked to
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Figure 1. Genome-wide Base-Resolution Identification of ASM in the Mouse Frontal Cortex
(A) The methylome sequencing depths for F1i and F1r and the number of SNPs between the parental 129 and Cast genomes are shown.
(B) A pie chart showing the percentages of total methylcytosine events that occur in the contexts of CG, CHG, and CHH for F1i (the first numbers) and F1r (the
second numbers). Numbers of methylcytosine events resulting from bisulfite conversion failure (based on the conversion rate) were subtracted from the total
numbers of methylcytosine events for CGs, CHGs, and CHHs.
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allele-specific gene expression (Chen et al., 2011; Gertz et al.,
2011; Hellman and Chess, 2010; Kerkel et al., 2008; Schalkwyk
et al., 2010; Schilling et al., 2009; Shoemaker et al., 2010; Zhang
et al., 2009). Currently, it is not entirely clear what sequence
determinants are important for such allelic DNA methylation.
Previous large-scale approaches identifying ASM primarily
relied uponmethylation-sensitive restriction enzyme or immuno-
precipitation of methylated DNA (Cooper and Constaˆncia, 2010;
Tycko, 2010). Thesemethods suffered froma low resolution con-
strained by the limited number of restriction sites or the size of
fragmented DNA. A novel microarray-based approach allowed
the investigation of over 27,000 CG sites in human promoter
regions for possible imprinted ASM sites at single-nucleotide
resolution (Avila et al., 2010; Choufani et al., 2011). Recently,
next-generation sequencing-based tools such as MethylC-
Seq, BS-Seq, and RRBS (reduced representation bisulfite
sequencing) enabled efficient base-resolution mapping of DNA
methylation (Cokus et al., 2008; Lister et al., 2008; Meissner
et al., 2008). Their application to mammalian cells has led to
the identification of ASM at thousands of CG sites in the human
genome (Chen et al., 2011; Gertz et al., 2011; Shoemaker et al.,
2010).
Here we present a genome-wide, base-resolution ASMmap in
mice, generated by applying MethylC-Seq to the mouse frontal
cortex from reciprocal crosses between two distantly related
inbred strains. Taking advantage of 20 million single-nucleo-
tide polymorphisms (SNPs) present in these two strains, we
were able to identify virtually all known imprinted gDMRs and
23 candidate imprinted DMRs. Further, we demonstrated the
presence of non-CG methylation in the adult mouse brain and
showed that it could also occur in an allele-specific manner.
Finally, we investigated the determinants underlying sequence-
dependent ASM at 131,765 CG sites and revealed a conserved
sequence preference of DNA methylation machinery.
RESULTS
Identification of Parent-of-Origin and Sequence-
Dependent ASMat BaseResolution in theMouse Frontal
Cortex
To investigate allele-specific DNAmethylation genome wide, we
performed reciprocal crosses between two inbred mouse
strains, 129X1/SvJ (129) and Cast/EiJ (Cast), and conducted
MethylC-Seq (Lister et al., 2009) using frontal cortex DNA from
adult F1 progenies of the initial cross 129 (mother) 3 Cast
(father) (denoted hereafter as F1i) and the reciprocal cross(C) A pie chart showing the percentages of MethylC-Seq reads assigned to their
(D) The percentages of cytosines in the mouse genome covered by at least one
(E) The Fisher’s exact test was used to identify parent-of-origin and sequence-dep
events (middle) or all CGs subjected to the Fisher’s exact test (bottom). TSS, tra
(F) A chromosome-wide (chr7) view of AS scores for parent-of-origin dependent AS
and sequence-dependent ASM (S-AS score; dark brown, the 129 allele methylate
scores by assigning reads randomly to two arbitrary alleles (R-AS score; black).
(G) A zoomed-in view of (F) for a region near imprinted genes Peg3 and Usp29 (to
red, maternal; blue, paternal) in each strain are also shown (bottom).
(H) A zoomed-in view of (F) for a region near Abcc8 showing sequence-depende
A further enlarged region with two sequence-dependent ASM sites is shown in (
See also Figure S1.
818 Cell 148, 816–831, February 17, 2012 ª2012 Elsevier Inc.Cast (mother)3 129 (father) (denoted hereafter as F1r).Wegener-
ated 1.54 billion (25.4 3 per strand) and 1.33 billion (22.1 3
per strand) uniquely mapped reads, respectively, from F1i and
F1r (Figure 1A and Figure S1A available online). The bisulfite
conversion rates were 99.50% for F1i and 99.51% for F1r
(Extended Experimental Procedures). To distinguish parental
origins for alleles in the progeny strains, we first identified 20.4
million SNPs between the 129 genome (sequenced in this study,
14.73 coverage) and the Cast genome (Keane et al., 2011). Due
to these genetic polymorphisms, 9.7% of CGs, 1.8% of CHGs,
and 1.2% of CHHs in the 129 genome are disrupted in the
Cast genome. In subsequent analyses, we focused primarily on
the CGs, CHGs, and CHHs common to both the 129 and Cast
strains. In F1i, 1.15 billion cytosinemethylation events were found
in all mapped reads (Figure 1B). Surprisingly, a significant
fraction of these events correspond to cytosines in non-CG con-
texts (8% from CHG and 27% from CHH). The average non-CG
methylation levels found here are comparable to those observed
in human embryonic stem cells (hESCs) (Lister et al., 2011) (Fig-
ure S1B). Similar observations were also made for F1r (Figures
1B and S1B), suggesting that non-CGmethylation is also present
in the mouse frontal cortex (discussed in detail later).
We next determined parent-of-origin dependent (imprinted)
and sequence-dependent ASM. Using the above SNP table,
we assigned 527 million MethylC-Seq reads to their parental
origins in F1i (34% of total reads, Figure 1C). Throughout the
genome, 36.7%, 37.3%, and 29.5%of CG, CHG, and CHH sites,
respectively, are covered by at least one read from each parental
allele (Figure 1D). Similar observations were made for F1r. We
first focused our studies on CGs and investigated only those
that had at least 53 coverage of each allele in each strain (n =
5,925,555). We selected CGs that showed consistent allele
bias (parent-of-origin or sequence-dependent) for DNAmethyla-
tion in both strains. The significance of such bias at each CG site
was assessed by the Fisher’s exact test using allelic reads
pooled from both strains (Figure 1E, top). We then used the p
values from the test and computed an ‘‘allele-specific score’’
(AS score, log10(p value)) to reflect DNA methylation bias for
the parent of origin (P-AS score, with positive and negative
values assigned for the maternal and paternal preferences,
respectively) or the strain background (sequence) (S-AS score,
with positive and negative values assigned for the 129 and the
Cast preferences, respectively). To estimate the false discovery
rate (FDR), we randomly permuted the allele assignment of each
read and computed the AS scores in parallel (R-AS score,
Extended Experimental Procedures). As shown in Figure 1F,parental origins for F1i (the first numbers) and F1r (the second numbers).
read from both alleles are shown as bar graphs for F1i (orange) and F1r (blue).
endent ASM (top). The genomic distributions are shown for the identified ASM
nscription start site; TES, transcription end site.
M (P-AS score; red, maternally methylated [M]; blue, paternally methylated [P])
d [129]; light brown, the Cast allele methylated [Cast]). A control track shows AS
p). The CG methylation levels (data from both strands combined; green, total;
nt ASM.
I).
Table 1. Imprinted DMRs Identified in This Study
Known Imprinted DMRs (n = 32)
Novel DMRs (n = 23)
Novel DMRs within or Near Known Imprinted Loci (n = 12)
Chr Locus Chr Locus Imprinting Gene Activity nearby CGI GC Content
chr1 Gpr1/Zdbf2* chr2 H13 DMR2 (30 end) known imprinting locus, K4me3 yes 0.60
chr2 Mcts2/H13* chr7 Snrpn U exon known imprinting locus, RNA no 0.52
chr2 Nesp chr7 AK086712 promoter known imprinting locus, K4me3, RNA no 0.47
chr2 Nespas/Gnasxl* chr7 U80893 upstream known imprinting locus, K4me3 no 0.39
chr2 Gnas1a* chr7 mir344b known imprinting locus, K4me3, K27ac no 0.42
chr6 Peg10/Sgce* chr7 mir344c known imprinting locus, K27ac no 0.41
chr6 Mest (Peg1)* chr7 mir344 known imprinting locus, K27ac no 0.45
chr6 Herc3/Nap1l5* chr7 mir344-2 known imprinting locus, K4me3, K27ac no 0.44
chr7 Peg3/Usp29* chr7 mir344g known imprinting locus, K4me3, K27ac no 0.37
chr7 Snurf/Snrpn* chr7 Magel2-Mrkn3 intergenic known imprinting locus, K4me3 no 0.51
chr7 Ndn chr11 Grb10 DMR2 (intragenic) known imprinting locus, RNA no 0.55
chr7 Magel2 chr11 Commd1 DMR2 (intragenic) known imprinting locus, RNA no 0.5
chr7 Mkrn3
Novel Diffuse DMRs within or near Known Imprinted Loci (n = 2)
chr7 Peg12
chr7 Inpp5f*
chr7 H19 promoter
chr7 H19 ICR* Chr Locus Imprinting Gene Activity nearby CGI GC Content
chr7 Kcnq1ot1* chr12 Gtl2-Mirg diffuse DMR known imprinting locus, RNA NA 0.45
chr7 Cdkn1c chr15 Eif2c2 diffuse DMR known imprinting locus, RNA NA 0.49
chr7 Cdkn1c upstream
Novel DMRs outside of Known Imprinted Loci (n = 9)
chr9 Rasgrf1*
chr10 Plagl1*
chr11 Grb10* Chr Locus Imprinting Gene Activity nearby CGI GC Content
chr11 Zrsr1/Commd1* chr6 Casc1 intragenic K4me3 no 0.51
chr12 Dlk1 chr7 6330408a02Rik 30 end K4me3 yes 0.62
chr12 Dlk1-Gtl2 IG* chr11 FR149454 promoter K4me3 no 0.53
chr12 Gtl2 chr12 FR085584 promoter K4me3 yes 0.52
chr15 Peg13* chr15 Myo10 intragenic K4me3 yes 0.61
chr15 Slc38a4* chr6 Vwde promoter no no 0.61
chr17 Airn* chr10 Neurog3 upstream no no 0.46
chr17 Igf2r chr13 Nhlrc1 downstream no yes 0.54
chr18 Impact* chr15 Pvt1 promoter no no 0.47
Known germline DMRs aremarked by ‘‘*.’’ CGI, DMRs overlapping with CpG islands; GC content, the GC content of DMRs (or a 200 bpwindow around
the DMR if a DMR is less than 100 bp); known imprinting locus, DMRswithin or near known imprinted loci; K4me3, allele-specific H3K4me3 enrichment
observed on the opposite allele of DNA methylation in the DMR; K27ac, allele-specific H3K27ac enrichment observed on the opposite allele of DNA
methylation in the DMR; RNA, allele-specific RNA transcripts observed on the opposite allele of DNAmethylation in nearby regions; NA, not available.clusters of parent-of-origin dependent ASM can be readily re-
vealed by the AS scores at known imprinted loci on chromosome
7, including Peg3/Usp29 (with a zoomed-in view shown in Fig-
ure 1G), the PWS-AS domain, Inpp5f, H19, Kcnq1ot1, and
Cdkn1c. Furthermore, sequence-dependent ASM sites, which
appear to be much more abundant, were also identified (Fig-
ure 1F). The majority of these ASM sites exist in isolation and
scatter along the chromosome (Figures 1H and 1I, discussed
in detail later).
Using a cutoff of AS score 3 (absolute value, corresponding to
p value = 0.001), we identified sequence-dependent ASM at131,765 CGs, compared to 2,737 ASM sites in random datasets
(FDR = 2.1%, Figure S1C). The same criterion, however, yielded
8,335 imprinted ASM sites with a high FDR of 32.8% (2,737/
8,335). By further applying more stringent criteria on these
8,335 CGs, we selected those that show either higher AS scores
(AS score R 5, absolute value, Figure S1C) or clustering with
other imprinted CGs (Figure S1D), resulting in a total of 1,952 im-
printed ASM sites with an FDR of 1.4% (Figure S1E). Compared
to the total CGs that we analyzed (Figure 1E, bottom), imprinted
ASM sites preferentially occur in the proximal promoters (Fig-
ure 1E,middle left). By contrast, sequence-dependent ASMsitesCell 148, 816–831, February 17, 2012 ª2012 Elsevier Inc. 819
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are typically found in intergenic and intronic regions and are rela-
tively depleted from the proximal promoters (Figure 1E, middle
right). Therefore these results suggest a distinct molecular basis
underlying these two types of ASM.
Identification and Analyses of Imprinted DMRs
As noted above, imprinted CGs are frequently found in clusters.
In fact, we found that the 1,952 imprinted ASM sites can be
grouped into 55 discrete genomic regions (Extended Experi-
mental Procedures), including 32 known DMRs (Table 1; see
Table S2 for full references). We expect to identify most of the
gDMRs. Indeed, among 22 gDMRs previously reported in mice
(Chotalia et al., 2009; Hiura et al., 2010; Schulz et al., 2008), 21
(95%) are found in our list (Table 1, marked by ‘‘*’’). A gDMR
near Nnat was not identified due to poor SNP coverage of the
locus. Further examination of MethylC-Seq reads covering this
region showed that CGs in these reads are either fullymethylated
or not methylated at all, supporting the presence of ASM events
(Figure S2A). For themajority of the known DMRs, their sizes that
we identified are consistent with those reported previously (Fig-
ure S2B). Certain variations of DMR boundaries identified in this
and prior studies may reflect incomplete coverage of SNPs,
different assays, or the dynamic changes of DMRs in various
cell types or developmental stages (Tomizawa et al., 2011).
In addition to reported imprinted DMRs, we also found 23
novel DMRs, among which 14 are either near or within the known
imprinted domains (Table 1). Interestingly, 9 of these 14 DMRs
(those on chromosome 7) reside in the PWS-AS domain, muta-
tions in which are responsible for Prader-Willi Syndrome and An-
gelman Syndrome (Nicholls and Knepper, 2001). We also found
two large DNA domains (the Gtl2-Mirg and the Eif2c2 diffuse
DMRs) that contain lower density of imprinted CGs than that of
other DMRs (Figures 4A and S5A, discussed later). Lastly, 9
novel DMRs (Casc1 intragenic, 6330408a02Rik 30 end,
FR149454 promoter, FR085584 promoter, Myo10 intragenic,
Vwde promoter, Neurog3 upstream, Nhlrc1 downstream, and
Pvt1 promoter) are distant from any known imprinted domains
(>5 megabase pairs). Of these 9 DMRs, four colocalize with
CpG islands, and 7 are in GC-rich regions (GC content > 0.5,
compared to 0.42 for the genome average) (Table 1).
To search for potential imprinted transcriptional activities near
these novel DMRs, we performed RNA-Seq in the mouse frontal
cortex. In the same tissue, we also carried out ChIP-Seq assays
for two histone modifications associated with gene activities:
H3K4me3 (K4me3) and H3K27ac (K27ac). Parent-of-origin AS
scores were computed for each data type to assess their allelic
bias (Extended Experimental Procedures). As shown in Fig-
ure 2A, AS scores for RNA and histone modifications accuratelyFigure 2. Identification of Known and Novel Imprinted DMRs in the Mo
(A) Total (green) and allelic (red, maternal; blue, paternal) levels of RNA, K4me3, K
shown for a region containing Peg3 and Usp29. The ChIP-Seq data were input-
DMR in this study.
(B) A similar graph as (A) is shown for a region containingNdn,Magel2,Mkrn3, and
coverage (blue arrow) are indicated.
(C) A similar graph as (A) is shown for a region containing amicroRNA gene cluster
(shaded) are indicated by red arrows, ‘‘*,’’ and ‘‘+,’’ respectively.
See also Figure S3.reflect preferential paternal enrichment of K4me3, K27ac, and
RNA transcripts at Peg3 and Usp29, two genes known to be
paternally expressed. In sum, for 19 out of 23 novel DMRs re-
ported in this study, we have found evidence in nearby regions
(135 kb for the Snrpn U exon DMR and <20 kb for the rest of
the 18 DMRs) for parent-of-origin dependent transcription and/
or active histone mark enrichment (Table 1 and described
below). For the remaining 4 DMRs (Vwde promoter, Neurog3
upstream, Nhlrc1 downstream, and Pvt1 promoter), we did not
find imprinted gene activity within 5 megabase pairs.
Figure 2B shows an example of newly identified DMRs in the
PWS-AS domain, including a cluster of paternally expressed
genes: Ndn, Magel2, Mkrn3, and Peg12 (based on our RNA-
Seq data, in the mouse frontal cortex, Magel2, Mkrn3, and
Peg12 are not expressed). In mice, evidence of DMRs was re-
ported for all four genes (see Table S2 for full references).
Consistently, we found maternally methylated DMRs at the
promoters of these genes. Further we found a novel DMR in
the intergenic region between Magel2 and Mkrn3 (Figure 2B,
red arrow). This DMR is marked by a paternal K4me3 peak, sug-
gesting the existence of an unannotated gene that is potentially
imprinted.
Notably, we also found maternally methylated DMRs, each
containing 1–5 CGs, at 5 microRNA genes (mir344b, mir344c,
mir344, mir344-2, and mir344g) in the PWS-AS domain (Fig-
ure 2C, red arrows). These genes are part of the mir344 gene
cluster that includes 5 other microRNA genes (Figure 2C). It is
currently unknown whether genes in the mir344 cluster are im-
printed (Royo and Cavaille´, 2008). The lack of SNPs in themature
microRNA sequences has prevented us from directly assessing
the imprinting status of these microRNA genes. Our RNA-Seq
analysis, which only assayed RNA molecules greater than
50 bp and therefore cannot capture microRNA expression, did
reveal a paternal transcript that appears to initiate from the
promoter of an upstream gene, AK086712 (data not shown),
and extend into the mir344 cluster (Figure 2C, track ‘‘RNA
Total’’). Interestingly, we found strong paternal enrichment of
K4me3 at mir344g (which shares a promoter region with
AK080655 and AK083195) and weak paternal peaks of K4me3
at mir344b, mir344-2, and mir344f (Figure 2C, marked by ‘‘+’’).
Paternal enrichment of K27ac at these microRNA genes is
even more evident, appearing at 9 out of the 10microRNA genes
(Figure 2C, marked by ‘‘*’’). Therefore, the presence of imprinted
DMRs and active histone marks at the mir344 gene cluster not
only strongly supports their imprinted status but also suggests
an autonomous transcription mechanism for these microRNA
genes by utilizing their own promoters. The remaining novel
DMRs are included in Figure S3.use Genome
27ac (RPKM values), and CG methylation, together with their P-AS scores, are
normalized. The shade denotes the approximate area harboring the identified
Peg12with DMRs shaded. A novel DMR (red arrow) and a regionwith poor SNP
(mir344). DMR, K27ac, and K4me3 peaks that colocalize withmicroRNA genes
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Identification of Non-CG Methylation in the Mouse
Frontal Cortex
As described above, a large fraction of methylcytosines occur in
the non-CG context in the adult mouse frontal cortex (Figures 1B
and 3A). Although the methylation level for most non-CG sites is
low in the frontal cortex genome, a significant number of non-CG
sites are highly methylated (Figure 3B). We detected over 3.1
million and 2.6 million non-CG sites with methylation levels
greater than 0.4 (coverage R 10) in F1i and F1r, respectively.
These are comparable to the number of methylated non-CG
sites using the same threshold (0.4) in hESCs (2.3 million,
calculated from Lister et al., 2009). To validate the presence of
non-CG methylation, we took three experimental approaches.
First, we showed that the MethylC-Seq data were well repro-
duced using bisulfite-PCR coupled with Sanger sequencing at
three genomic loci (Figure S4A). Second, we determined DNA
methylation genome wide using a DNA methylation-dependent
enzyme, FspEI. FspEI recognizes the CmC motif, in which the
second cytosine is methylated and can be in the context of
CG, CHG, or CHH (Zheng et al., 2010). We sequenced the
FspEI-digested genomic DNA from the mouse frontal cortex
(F1i and F1r) and control cells IMR90 and MEF (Figures S4B
and S4C). In IMR90 and MEF, methylcytosines corresponding
to the FspEI cut sites are predominantly CGs (Figure 3C). By
contrast, we found a large fraction of non-CG methylation at
the FspEI cut sites in the frontal cortex genome. Importantly,
the average number of FspEI cuts per cytosine positively corre-
lates with cytosine methylation levels obtained from MethylC-
Seq for CGs, CHGs, and CHHs (Figure 3D). This is not the
case when BstNI, a methylation-independent restriction
enzyme, was used in DNA digestion before subsequent
sequencing (Figure 3D). Finally, abundant non-CG methylation
was also observed in the parental strains 129 and Cast when
we sequenced their methylomes (12.53 and 12.83 per strand,
respectively) (data not shown). Therefore, we conclude that
non-CG methylation is indeed present in the adult mouse brain.
We next investigated the genomic distribution of non-CG
methylation. A chromosome-wide view of CG and non-CGmeth-
ylation revealed that, although CHG and CHH methylation
correlate fairly well, CG and non-CGmethylation showboth simi-
larities and differences (Figure 3E). This is also true genome wide
as non-CG methylation only moderately correlates with CG
methylation (Figure 3F), suggesting that non-CG methylation is
not simply a side product of CG methylation. An analysis ofFigure 3. Non-CG Methylation Is Present in the Mouse Frontal Cortex
(A) Themethylation levels for CHG, CHH, andCGare shown near two examples of
data from the forward strand are shown for non-CG methylation.
(B) The numbers of cytosines (coverageR 10) at various methylation levels are
(C) The percentages of CGs, CHGs, and CHHs corresponding to FspEI cut sites i
CHGs, and CHHs in the CC motif (the second cytosine) in the mouse and human
(D) The average numbers of FspEI or BstNI cuts per recognized cytosine are plot
recognizes CCWGG (W = A or T) where the second cytosine in the CHG context
(E) A chromosome view (chr12) of CG (blue), CHG (green), and CHH (red) methy
methylation show different distributions.
(F) Pearson correlation coefficients are shown for pairwise comparison of CG, C
(G) Sequence logos are shown for bases proximal to hypermethylated CHG
coverageR 10).
See also Figure S4.DNA sequences around hypermethylated CHGs and CHHs re-
vealed strong enrichment of motifs that largely resemble those
found in hESCs (Figure 3G) (Lister et al., 2009). In summary,
non-CG methylation has distinct distributions compared to CG
methylation in the frontal cortex.
Allele-Specific Non-CG Methylation at Imprinted Loci in
the Mouse Frontal Cortex
We then asked whether non-CG methylation might also occur in
a parent-of-origin dependent manner. We computed the parent-
of-origin AS scores for non-CG methylation (Extended Experi-
mental Procedures) and examined the methylation allele bias
at known imprinted loci. Indeed, parent-of-origin dependent
non-CG methylation is evident at eight imprinted loci (the Gtl2-
Mirg domain, the PWS-AS domain, Kcnqot1, Trappc9/Peg13,
Gpr1, Sgce, Rasgrf1, and Grb10), including most imprinted
regions of large size (see below and data not shown). One
such locus, the Gtl2-Mirg domain, is located in the Dlk1-Dio3
imprinting cluster, which is known to be essential for embryonic
development (da Rocha et al., 2008). The Dlk1-Dio3 domain
contains at least three paternally expressed genes, Dlk1, Rtl1,
and Dio3 (which all appear to be silenced in the mouse frontal
cortex, Figure 4A and data not shown), and multiple maternally
expressed noncoding RNA genes, including Gtl2, Rian, and
Mirg. We observed a single H3K4me3 peak at theGtl2 promoter,
followed by a region of continuous maternal transcription that
appears to span the entireGtl2-Mirg domain (Figure 4A, shaded),
supporting the existence of a single noncoding transcript initi-
ating from Gtl2 (Tierling et al., 2006). In the same region, we
observed paternal enrichment of non-CG methylation. This is
true for both CHG and CHH methylation (Figure 4A) and in
both F1i and F1r (data not shown), thus strongly arguing that
the presence of non-CG methylation is not due to the failure of
bisulfite conversion, in which case both parental alleles would
be affected equally.
Interestingly, in addition to the non-CG methylation DMRs
present in the Gtl2-Mirg domain, we also found evidence of
a large CG DMR (206 kbp) in the same region that contains at
least 205 paternally methylated CGs. These imprinted CGs in
this DMR are relatively scattered (the median number of neigh-
boring imprinted CGs in a 5 kb window is 8, compared to 31
for all other imprinted CGs, t test p value = 4E-205). This is in
contrast to other CG DMRs including those previously identified
in the Dlk1-Dio3 cluster (DMR1-DMR3, Figure 4A) (Takada et al.,genomic loci (pooled data from F1i and F1r, coverageR 10). For simplicity, only
shown as bar graphs for CHG and CHH in F1i and F1r.
n IMR90, MEF, F1i, and F1r are plotted as pie charts. The percentages of CGs,
genomes are also shown.
ted against the cytosine methylation levels determined by MethylC-Seq. BstNI
shows abundant methylation in the mouse cortex (data not shown).
lation levels (10 kb window). Arrows indicate regions where CG and non-CG
HG, and CHH methylation levels in F1i and F1r genome wide.
s (mCHG/CHG R 0.3, coverage R 10) and CHHs (mCHH/CHH R 0.5,
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2002). These imprinted CGs do not appear to colocalize with the
promoters of annotated genes in this region, includingmicroRNA
genes and snoRNA genes (Figure 4A, bottom). Therefore, we
considered it as a special ‘‘diffuse DMR.’’ A similar diffuse
DMR is observed at the Eif2c2 locus just outside of the
Trapp9/Peg13 imprinted domain (Figure S5A). In summary,
parent-of-origin dependent DMRs are present for both CG and
non-CG methylation in the Gtl2-Mirg domain.
Notably, the non-CG methylation in the Gtl2-Mirg domain is
present on a silenced allele (Figure 4A). This is also confirmed
by the FspEI digestion assay, which shows preferential cut of
the paternal allele in the Gtl2 domain but not in two regions
nearby (‘‘Gtl2 left’’ and ‘‘Gtl2 right’’) (Figure 4B). Similarly we
found non-CG methylation occurring on the repressed allele of
the imprinted Kcnq1ot1 (Figures S5B and S5C) and four other
imprinted genes (Peg13, Sgce, Grb10, and Rasgrf1; data not
shown). Further, whereas CG DMRs (except for diffuse CG
DMRs) in these imprinted loci are preferentially located at the
promoters/upstream regions, non-CG DMRs often extend into
gene bodies (Figure S5B and data not shown). We then exam-
ined the relationship of non-CG methylation and gene activity
in the entire genome. Consistent with previous findings (Lister
et al., 2009), we found that at promoters, both CHG and CHH
methylation inversely correlate with gene expression (Figure 4C).
However, in gene bodies, in striking contrast to the reported
positive correlation between non-CG methylation and gene
activity in hESCs (Lister et al., 2009), both CHG and CHH meth-
ylation negatively correlate with gene expression in the mouse
frontal cortex (see Discussion). Taken together, these data not
only demonstrate that non-CG methylation in the mouse frontal
cortex correlates with gene activity but also suggest that it
may be regulated differently from that in hESCs.
Characterization of Genomic Regions Associated with
Sequence-Dependent ASM
Compared to parent-of-origin dependent ASM, sequence-
dependent ASM sites are very abundant in the mouse genome
(Figure 1F). We confirmed that sequence-dependent ASM was
not due to mapping bias between the two alleles (Figure S6A).
Such methylation bias is not only present between the 129 and
Cast alleles in F1i and F1r but is also apparent between the
parental 129 and Cast strains (Figures 5A and S6B), indicating
that it is likely inherited from parental strains in a sequence-
dependent manner. A genomic distribution analysis revealed
that the level of sequence-dependent ASM (S-AS score) is
largely uniform in regions near genes with the exception of the
proximal promoters, where ASM is depleted at genes with high
or medium expression levels (Figures 5B and S6C). ThisFigure 4. Parent-of-Origin Dependent Non-CG Methylation in the Mou
(A) Total and/or allelic levels of RNA, K4me3, CHG methylation, CHH methylation
Gtl2-Mirg domain (top). CG DMRs (DMR1-3 and the diffuse CG DMR) and non-C
with the locations of microRNA and snoRNA genes indicated (bottom).
(B) The numbers of CGs, CHGs, andCHHs corresponding to FspEI cut sites on the
and ‘‘Gtl2 right’’), or the entire genome are shown as bar graphs. The p values fo
(C) The average methylation levels for CG, CHG, and CHH are shown along the pr
UTR, and downstream regions (2.5 kb downstream of TESs) for all RefSeq genes
levels of expression (FPKM values, average of F1i and F1r).
See also Figure S5.phenomenon may be partly due to low levels of CG methylation,
SNP density, and a high level of conservation associated with
active genes (Figures S6D–S6H). Nevertheless, genes depleted
of ASM are strongly enriched in those coding for homeobox
proteins, transcription factors, development regulators, as well
as histones and ribosome proteins (Figure S6I). We did not find
any gene ontology enrichment for genes that show the most
abundant sequence-dependent ASM. These results suggest
that DNA methylation at the promoters of some key develop-
mental regulators and housekeeping genes is subject to strin-
gent regulation.
We then examined the relationship between sequence-
dependent ASM and allele-specific gene expression (ASE).
Unlike imprinted ASM, most sequence-dependent ASM sites
(93.2%) are present in isolation (Figure 5C). Such ASM does
not appear to correlate with ASE genome wide (data not shown).
A small fraction of sequence-dependent ASM sites (6.8%, n =
9,030) do show clustering and can be grouped into 1,051
DMRs (Figure 5D). Of these sequence-dependent DMRs, the
majority fall into intergenic regions (39.7%) and introns
(34.3%), yet 141 (13.5%) are present at gene promoters. We
examined the downstream genes that are likely to be regulated
by promoter-associated sequence-dependent DMRs. Among
the 94 genes for which allelic expression or K4me3 state could
be ascertained, 20 (21.3%) show allele-specific transcription or
K4me3 enrichment that inversely correlates with the DNA meth-
ylation status (see Figure 5E for an example). The rest display no
significant allelic bias in gene activity. These data are consistent
with a study in humans (Gertz et al., 2011), suggesting that
a small fraction of sequence-dependent ASM sites are clustered
and may influence allele-specific gene expression.
Sequence-Dependent ASM Reveals a Sequence
Preference for DNA Methylation
To determine what genetic variations may contribute to
sequence-dependent ASM, we next examined the SNP
frequency near sequence-dependent ASM sites. Indeed, an
elevated SNP density is associated with these allelicly methyl-
ated cytosines (Figure 6A). Interestingly, the SNPs at the 1
and +1 positions show a strong bias in base composition (Fig-
ure 6B). On the hypermethylated allele, there is a strong enrich-
ment of G and C at the 1 and +1 positions, respectively. By
contrast, on the hypomethylated allele, A and T/A are preferen-
tially present at the 1 and +1 positions, respectively. Impor-
tantly, this is not observed for a random set of CGs (Figure 6B).
Togther, these results revealed the over-representation of
GCG/CGC and ACG/CGT motifs on the hyper- and hypomethy-
lated alleles, respectively (Figure 6C). We next hypothesized thatse Frontal Cortex
, and CG methylation, together with their P-AS scores, are shown for the Dlk1-
G DMRs are indicated. A zoomed-in region for the Gtl2-Mirg domain is shown
maternal and paternal alleles in theGtl2 domain, two regions nearby (‘‘Gtl2 left’’
r the allelic bias (binomial distribution) are also shown (‘‘*,’’ p value < 0.01).
omoter (2.5 kb upstream of TSSs), 50 untranslated region (UTR), exon, intron, 30
with high (top 1/3, red), medium (middle 1/3, blue), and low (bottom 1/3, green)
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Figure 5. Genome-wide Localization of Sequence-Dependent ASM
(A) The CGmethylation levels of the sequence-dependent ASM sites (ranked by the S-AS scores) are shown for the 129 allele and Cast allele for F1i and F1r (left).
The methylation levels for the same CG sites in the parental 129 and Cast strains (coverageR 10) are also shown (right).
(B) The average S-AS scores (absolute value) are shown along the promoter (2.5 kb upstream of TSSs), 50 UTR, exon, intron, 30 UTR, and downstream regions (2.5
kb downstream of TESs) for all RefSeq genes with high (top 1/3, red), medium (middle 1/3, blue), and low (bottom 1/3, green) levels of expression.
(C) The percentages of scattered and clustered sequence-dependent ASM sites are shown in a pie chart.
(D) Genomic distribution of sequence-dependent DMRs (median length = 1,010 bp) is shown in a pie chart.
(E) An example gene, AK020375, shows the 129 allele-specific promoter CG methylation (red arrow) and the Cast allele-specific K4me3 enrichment and tran-
scription. A region with poor SNP coverage is indicated.
See also Figure S6.
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such sequence preference for DNA methylation may exist in the
entire genome. To test this, we used combined F1i and F1rmeth-
ylome data to examine methylation levels of various 4-mer CG
motifs (CG plus -1 and +1 bases, or NCGN) throughout the
genome. We excluded CpG islands (CGIs) and promoters in
our analysis, as these regions are generally depleted of DNA
methylation in part due to the presence of antagonistic
H3K4me3 (Jia et al., 2007; Ooi et al., 2007; Thomson et al.,
2010). Indeed, GCGC exhibits the highest level of methylation
among all 4-mer motifs (Figure 6D), and it is followed by motifs
that contain either a GCG or CGC signature. Those containing
an ACG or CGT motif are ranked lowest in DNA methylation.
This is not simply related to GC content, as motifs with similar
GC contents (Figure 6D, marked by ‘‘*’’ or ‘‘#’’) demonstrate
distinct methylation levels. The hyper- and hypomethylated
motifs also do not show significant differences in their locations
in relation to genes (excluding the promoters, Figure S7A) or
repetitive sequences (Figure S7B). We conclude that the CG
methylation dependence on the 1 and +1 flanking positions is
observed both at the sequence-dependent ASM sites and on
a genome-wide scale.
We further asked whether any bases beyond the 1 and +1
positions may also influence CG methylation, particularly those
at the 2 and +2 positions, where SNPs show the highest A+T
percentages on the hypermethylated allele and the lowest A+T
percentages on the hypomethylated allele (Figure 6B). We
therefore examined 13,584 sequence-dependent ASM sites
that contain SNPs at the 1, 2, +1, or +2 positions. At these
sites, various 6-mer motifs (NNCGNN) demonstrated distinct
frequencies on the hyper- and hypomethylated alleles (Fig-
ure 6E and Table S3), many of which are of high statistical
significance (Figure 6F). For example, CTCGCG is observed
235 times (86%) on hypermethylated alleles but only 39 times
(14%) on hypomethylated alleles (p value = 2E-33, binomial
test). To quantify such methylation preference for each motif,
we used a Bayesian model to compute a ‘‘methylation index’’
based on the motif’s relative occurrence on hyper- and hypo-
methylated alleles (Extended Experimental Procedures). As
for the 4-mer motifs, we asked whether such DNA methylation
preference for the 6-mer motifs also holds true in the genome.
Indeed, we observed a positive correlation (R = 0.73) between
the median methylation level in the genome and the methyla-
tion index for each motif (Figure 6G). Interestingly, the correla-
tion is higher (R = 0.85) when excluding motifs containing
tandem CGs (such as CGCGCG or CGCGGT). Further, we
also examined 14 recently published human methylomes (Lister
et al., 2011). Again, we observed strong correlation for various
6-mer motifs between their methylation indexes derived from
mice and their methylation levels in humans (see Figure 6H
for an example in IMR90). Interestingly, the correlations are
lower for hESCs and human induced pluripotent stem cells
(hiPSCs) than for human somatic cells (Figure 6I), possibly
due to the high levels of DNA methylation in hESCs and
hiPSCs, which likely diminish the differences of methylation
levels among various motifs (Figure S7C). In summary, we
found that CG methylation is significantly influenced by the
immediate flanking bases, a feature that appears to be
conserved from mice to humans.DISCUSSION
A Genome-wide, Base-Resolution Survey of Imprinted
ASM in the Mouse Genome
Differentially methylated regions between two alleles are crit-
ical for genomic imprinting and proper embryogenesis (Barto-
lomei and Ferguson-Smith, 2011). In this study, we have
performed a comprehensive survey of ASM in the mouse
genome, uncovering virtually all known imprinted gDMRs, as
well as 23 new imprinted DMRs. These novel DMRs should
help identify new regulatory regions for known imprinted genes
or discover new imprinted loci. Among them, of particular
interest are two atypical DMRs (the Gtl2-Mirg and the Eif2c2
diffuse DMRs) containing relatively scattered imprinted CGs.
Currently, it is not clear whether the diffuse DMRs are a cause
or a result of the allele-specific transcription. Therefore, a novel
imprinting mechanism may exist in this DMR that calls for
future study. In addition, such DMRs allow the identification
of novel imprinted genes whose imprinting status is difficult
to determine, including those that show monoallelic expression
only in certain tissues and microRNA genes that have short
mature transcripts. We also compared DMRs identified in this
study to a recent genome-wide survey of imprinted genes in
the mouse (Gregg et al., 2010), which reported over a thousand
imprinted genes in the embryonic brain, adult cortex, and
hypothalamus. Surprisingly, we found that most of the novel
imprinted genes found by Gregg et al. are far away from the
DMRs identified in the present study (93% are at least 1 meg-
abase pair away from any DMRs, compared to 2% for known
imprinted genes). Similar to two previous studies (Babak et al.,
2008; Wang et al., 2008), our own RNA-Seq data also failed to
reveal the imprinting status of most novel genes reported in
Gregg et al. (data not shown). It is possible that DNA methyla-
tion-independent imprinting mechanisms may be responsible
for the large number of imprinted genes reported by Gregg
and colleagues. Alternatively, the discrepancy may also arise
from differences in the strains or methods of data analyses
used in each study. Nevertheless, results from our study reveal
significant epigenetic differences between the two parental
genomes that will help elucidate the mechanisms of genomic
imprinting.
Evidence for Non-CG Methylation in the Mouse Frontal
Cortex
The discovery of abundant non-CG methylation events in the
adult mouse frontal cortex is surprising. In contrast to non-CG
methylation in hESCs (Lister et al., 2009), our data suggest
that non-CG methylation in the mouse frontal cortex is nega-
tively correlated with gene activity in transcribed regions. In
addition, we found that CHHs are more likely to be methylated
than CHGs in the mouse brain, whereas an opposite observa-
tion was made in hESCs (Lister et al., 2009). It is currently
unclear why non-CG methylation displays distinct distribution
patterns in these two types of cells. Interestingly, it has been
shown that DNMT3A, which has been implicated in methylation
at non-CG sites (Ramsahoye et al., 2000), is expressed in
different isoforms in ESCs and the brain. The major isoform ex-
pressed in ESCs, DNMT3A2, is preferentially enriched atCell 148, 816–831, February 17, 2012 ª2012 Elsevier Inc. 827
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Figure 6. Sequence-Dependent ASM Reveals Sequence Determinants of DNA Methylation
(A) The total number of SNPs at each base within ±50 bp of 131,765 sequence-dependent ASM sites (orange) is shown. A similar plot is shown for 131,765
random CG sites drawn from either all CGs selected for the ASM study (green) or all CGs in the whole genome (blue).
(B) The SNP base composition on the 129 (left) or the Cast (right) allele is shown for those near ASM sites that are preferentially methylated on the 129 allele
(top) or the Cast allele (middle). A similar analysis was done for a control set of random CGs of equal size drawn from all CGs selected for the ASM study
(bottom).
(C) The base composition for SNPs on the hyper- (left) or hypo- (right) methylated alleles near all sequence-dependent ASM sites is shown as a sequence logo.
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euchromatin, whereas the mouse brain only expresses
DNMT3A1 that selectively targets heterochromatin (Chen
et al., 2002), suggesting that different DNA methylation
machinery may exist in ESCs and the frontal cortex. Recently,
5-hydroxymethylcytosine (5hmC) has been found in mouse
brain cells (Kriaucionis and Heintz, 2009). The lack of a base-
resolution approach to measure 5hmC prevents us from quanti-
tatively distinguishing it from methylcytosine in the MethylC-seq
data. However, in the mouse brain, 5hmC appears to be de-
tected only at CG sites but not at non-CG (CA) sites (or below
the detection limit) (Kriaucionis and Heintz, 2009). It shows posi-
tive correlation with gene activity over transcribed regions (Song
et al., 2011), where non-CG methylation shows negative corre-
lation, suggesting that non-CG methylation is unlikely to be
a simple result of 5hmC. In conclusion, these findings suggest
that non-CG methylation is not limited to pluripotent cells and
may be subject to regulations by different mechanisms in hESCs
and the mouse brain.
Sequence-Dependent ASM Reveals a Sequence Code
for DNA Methylation
Although imprinted ASM is critical for development, our
genome-wide data suggest that the vast majority of differences
in DNA methylation between two parental genomes are
sequence dependent. In this study, we have focused on ASM
that does not involve the change of CG identities. We showed
that although most such ASM events are isolated and appear
to have little effect on gene expression, they provide a unique
opportunity for us to determine the sequence determinants of
DNA methylation. We demonstrate that DNA methylation at
CGs is strongly influenced by defined sequences in the imme-
diate neighborhood. Such sequence preference is not unique
to mouse frontal cortex but is also observed in multiple human
cell types, suggesting a conserved mechanism for regulation
of DNA methylation by adjacent sequences. These findings are
consistent with previous studies showing that DNMT3A and
DNMT3B, or the DNMT3A-interacting protein DNMT3L, may
be affected by the sequence context of their substrates (Chedin
et al., 2002; Jia et al., 2007;Wienholz et al., 2010). The hyper- and
hypomethylated motifs found here appear to be different from
those derived from DNA methylation patterns at several CpG
islands using the episomal methylation assay in a recent study
(Wienholz et al., 2010) but agree with DNA methylation motifs
discovered in Arabidopsis (Cokus et al., 2008; Lister et al.,
2008). Taken together, these data suggest the existence of an(D) The median methylation levels of various 4-mer CG motifs (‘‘Observed mCG/C
shown. Motifs that contain GCG/CGC or ACG/CGT signatures are in red or blue
content but with distinct methylation levels are indicated.
(E) The percentages of occurrences on hyper- (red) and hypo- (green) methylate
(F) The number of total occurrences on both alleles (blue bars, with the scale at the
reflecting allele occurrence bias (red bars, with the scale at the top) for each mo
(G) A scatter plot is shown for various 6-mer CG motifs, comparing the methylati
Motifs with tandem CGs (blue) or GCG/CGC signatures (red) are indicated. R, th
(H) A similar plot as (G) is shown for various 6-mer CG motifs, comparing the meth
genome of IMR90 (Lister et al., 2011).
(I) The Pearson correlation coefficients are shown comparing the methylation inde
14 human lines (Lister et al., 2011) for various 6-mer CG motifs.
See also Figure S7.evolutionarily conserved sequence code for DNA methylation.
Given that CpG islands and promoter regions are actively main-
tained in a hypomethylated state by H3K4me3 or other factors
(Jia et al., 2007; Ooi et al., 2007; Thomson et al., 2010), the
DNA methylation pattern is likely a result of methyltransferase
(or demethylase) actions influenced by transcription factors,
local sequence context, and chromatin environment. Our find-
ings set the stage for further investigation of how these factors
work together to establish the global DNA methylation land-
scape in mammalian genomes.
EXPERIMENTAL PROCEDURES
Strain Crosses
The crosses of the two mouse strains were performed at Jackson Laborato-
ries. The male parental strains and the F1 offspring were shipped at 8 to
9 weeks of age.
MethylC-Seq Library Generation and Sequencing
Genomic DNA was extracted from the frontal cortex of the F1 crosses or the
parental strains and was spiked in with unmethylated lambda DNA (Promega).
The DNA was fragmented by sonication. Purified DNA fragments were end-re-
paired and ligated to paired-end cytosine-methylated adapters provided by Il-
lumina. Size-selected adaptor-ligated DNA was treated with sodium bisulfite
using the EZ DNA methylation-Gold Kit (Zymo Research). The resulting DNA
molecules were enriched by PCR, purified, and sequenced following standard
protocols from Illumina.
ChIP-Seq Library Generation and Sequencing
Frozen frontal cortex from the F1 crosses was thawed on ice and processed
with a razor blade into small pieces. The tissue was then crosslinkedwith form-
aldehyde, washed, and homogenized and proceeded following a ChIP
protocol as described in the Extended Experimental Procedures. ChIP
libraries were prepared and sequenced following standard protocols from
Illumina.
RNA-Seq Library Generation and Sequencing
The frontal cortex from the F1 crosses was dissected, and RNA was isolated
followed by DNaseI treatment. RNA was treated with RiboMinus (Invitrogen)
to remove the ribosomal RNA. Libraries were prepared according to the SOLiD
sequencing protocol and sequenced at EdgeBio.
Data Analyses
Details of bioinformatic analyses can be found in the Extended Experimental
Procedures.
ACCESSION NUMBERS
All sequencing data were deposited to GEO under the accession number
GSE33722.G’’) across the frontal cortex genome (excluding the promoters and CGIs) are
, respectively. Examples of motif pairs (marked by ‘‘*’’ or ‘‘#’’) with similar GC
d alleles are shown for each 6-mer CG motif.
bottom) and the p value (binomial test, after Bonferroni multiple test correction)
tif in (E) are shown.
on indexes to the median methylation levels across the frontal cortex genome.
e Pearson correlation coefficient.
ylation indexes derived from mice to the median methylation levels across the
xes derived frommice to the median methylation levels across the genomes of
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